Taysha Gene Therapies competitorsClear all
Taysha Gene Therapies's top competitors include Voyager Therapeutics, Passage Bio, Lacerta Therapeutics and Oscine Therapeutics.
 Taysha Gene Therapies Taysha Gene Therapies is a biotechnology company that develops treatments to eradicate monogenic diseases of the central nervous system (CNS). |  Voyager Therapeutics Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). |  Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. |  Oscine Therapeutics Oscine Therapeutics is a company developing a cell therapy platform for the treatment of CNS diseases. | ||
Founding Date | Founding Date 2020 | Founding Date 2014 | Founding Date 2018 | Founding Date 2017 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Dallas, US HQ | Locations Cambridge, US HQ | Locations Philadelphia, US HQ | Locations Alachua, US HQ Alachua, US | Locations Rochester, US HQ |
Employees | Employees N/A | Employees 18550% increase | Employees 20 | Employees 462% decrease | Employees N/A |
Valuation ($) | Valuation ($) 106.6 m | Valuation ($) 244.8 m | Valuation ($) 109.1 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 394 | Twitter followers N/A | Twitter followers 572 | Twitter followers 117 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 14 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 2.9 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3.2 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 85.71% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 410427 | Alexa Website Rank 409759 | Alexa Website Rank 233667 | Alexa Website Rank 595798 | Alexa Website Rank N/A |
Employee Rating | Employee Rating N/A | Employee Rating 2.6 | Employee Rating 5 | Employee Rating 4.8 | Employee Rating N/A |
Financial | |||||
Net income | Net income ($60m) (FY, 2020) | Net income $36.7m (FY, 2020) | Net income ($112.2m) (FY, 2020) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 135m | Total funding raised $ 225.5m | Total funding raised $ 30m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Voyager Therapeutics
HQ
Cambridge, US
Employees
185↑ 50% increase
Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS).
View companyPassage Bio
HQ
Philadelphia, US
Employees
20
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
View company
Lacerta Therapeutics
HQ
Alachua, US
Employees
46↓ 2% decrease
Lacerta Therapeutics is a clinical stage gene therapy company.
View companyOscine Therapeutics
HQ
Rochester, US
Oscine Therapeutics is a company developing a cell therapy platform for the treatment of CNS diseases.
View company